AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT00454311 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: · day embryo biopsy
Study NCT04715386 — intervention group
Intervention type: DRUG
Intervention: StrataXRT
Description: Patients will be asked to start topical application of their allocated topical preparation on the area of skin that will be irradiated at the onset of radiation therapy, every day until skin symptoms subside (see patient information pamphlet). Apply twice per day and can be reapplied as skin symptoms arise or as needed. The amount of StrataXRT provided to each patient will be recorded throughout treatment.
Study NCT01210885 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Meningococcal Vaccine
Description: MenABCWY combination vaccine containing four different rMenB formulations with MenACWY, intramuscular (IM) administration, vaccination at 0 and 2 months.
Study NCT02303964 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Plasma
Description: Type A thawed plasma (up to 2 units) will be administered to polytrauma subjects randomized to plasma arm of study
Study NCT02303964 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Normal saline
Description: Normal saline will be administered to polytrauma subjects randomized to normal saline arm of study
Study NCT01817049 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: HAPA-based coach education workshop
Description: A 3.5 hour workshop will target HAPA constructs by providing injury risk information (risk perceptions), FIFA 11+ effectiveness evidence (outcome expectancies), and hands-on experience administering the 11+ program to a soccer team (task self-efficacy). Action planning and coping planning exercises will also be conducted.
Study NCT01210885 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Meningococcal Vaccine
Description: MenABCWY combination vaccine containing four different rMenB formulations with MenACWY, intramuscular (IM) administration, vaccination at 0 and 2 months.
Study NCT00297986 — intervention group
Intervention type: DEVICE
Intervention: Helmet
Description: Evaluation of different interfaces for NPPV
Study NCT01817049 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: placebo attention control
Study NCT02018055 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Aspirin+Ticagrelor
Description: Aspirin+ Ticagrelor after 1month of standard DAPT (Aspirin+Ticagrelor)
Study NCT02018055 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aspirin+Clopidogrel
Description: Aspirin+ Clopidogrel after 1month of standard DAPT (Aspirin+Ticagrelor)
Study NCT00659334 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ferumoxtran-10 (Combidex)
Description: 2.6 mg/kg
Study NCT02533388 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Hwato Electronic Acupuncture Treatment Instrument
Description: Thirty minutes prior to the induction of anaesthesia, the patients in the TEAS group started to receive TEAS by a stimulator (Hwato Electronic Acupuncture Treatment Instrument, model No.: SDZ-II, Suzhou Medical Appliances Co., Ltd., Suzhou, China) to the right hand, forearm and neck by an experienced acupuncturist at the Hegu (LI4), Neiguan (PC6), Lieque (LU7), Chize (LU5), Futu (LI18) and Renying (ST9) acupoints. TEAS was peformed with an alternate dense-disperse frequency of 2 and10 Hz ( 2 Hz for 10 s and 10 Hz for 5 s). The optimal intensity ranged from 6-15 mA, The stimulus continued until 5 min before the end of surgery.
Study NCT02533388 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Placebo
Description: The patients in the Sham group were also connected to the apparatus, but electronic stimulation was not applied.
Study NCT01000142 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Osteopathic Manipulative Treatment
Description: Focused osteopathic musculoskeletal exam; paraspinal muscle inhibition and/or soft tissue kneading or stretching; rib raising and or rib mobilization; abdominal diaphragm release technique; abdominal mesenteric/colon release; thoracic inlet release technique; hip flexion/extension range of motion; shoulder range of motion with pectoral traction; cervical paraspinal muscle inhibition and/or soft tissue kneading or stretching; suboccipital release technique; specific OMT of significant somatic dysfunction (variable).
Study NCT01000142 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Light Touch
Description: Focused osteopathic musculoskeletal exam; contact ribs to simulate rib raising and paraspinal muscle inhibition; contact lower rib margin to simulate abdominal diaphragm release; palpate the four quadrants of the abdomen to simulate abdominal mesenteric/colon release; contact shoulders to simulate thoracic inlet release; contact suboccipital region to simulate thoracic inlet release.
Study NCT01004900 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Selective Laser Trabeculoplasty
Description: This is a laser procedure used to treat glaucoma by reducing the pressure in the eye. SLT works by using laser light to stimulate the body's own healing response to lower your eye pressure. Using a special wavelength and energy, the laser affects only pigmented (melanin containing) cells of your eye. SLT improves the flow of fluid in the eye, which in turn lowers your eye pressure.
Study NCT01004900 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Travoprost/ Timolol/ Azopt/ Brimonidine
Description: Travoprost (Topical eye drops) administered once daily before sleep
Study NCT00821990 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Chemotherapy
Description: The administration of chemotherapy regimen (docetaxel or irinotecan) will be determined at the discretion of investigator, and depends on the patient's previous chemotherapy.
Study NCT00821990 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Best supportive care
Description: It includes nutritional support, analgesics, antibiotics, antiemetics, transfusions, or any other symptomatic therapy (with the exception of cytotoxic chemotherapy) and/or assistance of a psychological support. Localized radiotherapy to alleviate symptoms such as pain is allowed provided that the total dose delivered is in a palliative range.
Study NCT00890227 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Traditional technique
Description: All level open instrumented posterior spinal fusions
Study NCT00890227 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Minimally invasive technique
Description: Open surgery for all the levels except the proximal segment (most proximal instrumented level) where minimally invasive technique will be used.
Study NCT01188161 — intervention group
Intervention type: DEVICE
Intervention: Rotating Chair
Description: Subjects will be spun in rotating chair
Study NCT00085722 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Dextrose Prolotherapy
Description: Injection procedure: 50% dextrose is diluted with .9% 'normal' saline and 1% lidocaine to achieve 15% dextrose for ligament injections and 25% dextrose for intra-articular injection.
Study NCT00085722 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Saline Prolotherapy
Description: 7 mL 9% 'normal' saline and 3mL 1% lidocaine
Study NCT00085722 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: At-home physical therapy exercise group
Description: Subjects in the at-home physical therapy exercise group will receive a patient information pamphlet about knee osteoarthritis and conservative care instructions for standard at-home physical therapy exercises
Study NCT03137095 — intervention group
Intervention type: OTHER
Intervention: Cognitive testing
Description: computerized and paper-based cognitive tests that assess memory, executive function, processing speed and concentration performed at Assessments 1, 3, 4.5 \& 5.
Study NCT03137095 — intervention group
Intervention type: OTHER
Intervention: Research Brain MRI
Description: Optional sub-study participation includes undergoing research brain MRI to obtain structural and functional brain images at Assessment 4.5 and 6.
Study NCT00659334 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Neurosurgery
Description: neuro-surgical tumor biopsy or resection to assess particle localization. Biopsy (stereotactic, when possible) will take place following the 24 hour post- Combidex MR and within 48 hrs of i.v. Combidex administration. Biopsies will be taken from the tumor, brain around tumor (BAT) and brain distant to tumor and the MR localization and histology will be compared. The tissue will be obtained by either resection or needle frameless stereotactic biopsy.
Study NCT00659334 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Neurosurgery
Description: neuro-surgical tumor biopsy or resection to assess particle localization. Biopsy (stereotactic, when possible) will take place following the 24 hour post- Combidex MR and within 48 hrs of i.v. Combidex administration. Biopsies will be taken from the tumor, brain around tumor (BAT) and brain distant to tumor and the MR localization and histology will be compared. The tissue will be obtained by either resection or needle frameless stereotactic biopsy.
Study NCT00253864 — intervention group
Intervention type: PROCEDURE
Intervention: Single row
Description: Fixation type in arthroscopic rotator cuff repair.
Study NCT00253864 — intervention group
Intervention type: PROCEDURE
Intervention: Double row
Description: Fixation type in arthroscopic rotator cuff repair.
Study NCT02099734 — intervention group
Intervention type: BEHAVIORAL
Intervention: Questionnaires
Study NCT02099734 — intervention group
Intervention type: OTHER
Intervention: sample of blood or saliva
Description: A sample of blood or saliva will be obtained for DNA extraction. Approximately 2-4 tubes of blood will be collected or one tablespoon of saliva. If a participant has already provided a DNA sample for another MSKCC IRB approved protocol, they may not need to provide an additional sample.
Study NCT03186963 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: No immobilization
Description: Conventional wrist dressing
Study NCT01359553 — intervention group
Intervention type: OTHER
Intervention: Intra-articular ultrasound imaging of knee joint during arthroscopy
Study NCT01359553 — intervention group
Intervention type: OTHER
Intervention: Non-invasive ultrasound imaging of knee
Study NCT01359553 — intervention group
Intervention type: OTHER
Intervention: Quantitative MRI imaging of knee
Study NCT01359553 — intervention group
Intervention type: OTHER
Intervention: Contrast-enhanced CT imaging of knee
Study NCT05262153 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Non-surgically performed scaling and root planing
Description: Treatment of patients with periodontitis was performed using manual and ultrasonic instruments.
Study NCT03792113 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Periodontal Flap Surgery
Description: Periodontal access flap surgery will be performed in both test site followed by control site in each subject
Study NCT03792113 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Periodontal Flap Surgery
Description: Periodontal access flap surgery will be performed in both test site followed by control site in each subject
Study NCT03792113 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Autologous fibrin glue
Description: Autologous fibrin glue procured from the subject's own venous blood will be used to approximate periodontal flaps following access periodontal surgery
Study NCT03792113 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: 4-0 silk suture
Description: Conventional 4-0 black silk suture will be used to approximate periodontal flaps following access flap surgery
Study NCT01316926 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Test formulation
Description: Paroxetine Hydrochloride 25 miligrams (mg) tablet with controlled release (Paxil CR) manufactured by GlaxoSmithKline Inc. - Mississauga - Canada (test formulation)
Study NCT03186963 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Volar splint
Description: Volar plaster splint
Study NCT01124526 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rituximab Fludarabine Cyclophosphamide
Description: Patients receiving from 4 to 6 cycles of chemotherapy (R F C) each 4 weeks depending on haematological tolerance:~RITUXIMAB(R)375 mg/m2 iv,day 3 C1 and day 1 C2-C6,(total dose 375 mg/m2) FLUDARABINE(F):25 mg/m2 iv, day 1-3,(total dose 75 mg/m2) CICLOPHOSPHAMIDE(C)1000 mg/m2 iv, day 1,(total dose 1000 mg/m2)
Study NCT03223285 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Real Treatment Group
Description: Real Diaphragm manoeuvres The experimental manoeuvres include the Doming The Diaphragm Technique as described by Digiovanna (2004), Chila (2011) and Yao (2014) and the Manual Diaphragm Release Technique as described by Ricard (2009), De Coster (2005) and Roha (2015). Both manoeuvres are performed in two sets of 10 repetitions, within a 1-minute interval.~Multifaced physiotherapy/osteopathic treatment includes: vertebral mobilisations (C0-D1), high-velocity low-amplitude (HVLA) thrusts of the cervical spine, soft tissue techniques
Study NCT03223285 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Sham Treatment Group
Description: Sham Diaphragm manoeuvre: the physiotherapist will simply lie hands on the rib cage, and rest along the anterolateral costal margin below rib 7, during normal breathing of the patient for 40 breathes.~Multifaced physiotherapy/osteopathic treatment includes: vertebral mobilisations (C0-D1), high-velocity low-amplitude (HVLA) thrusts of the cervical spine, soft tissue techniques
Study NCT01316926 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Reference formulation
Description: Paroxetine Hydrochloride 25 mg tablets with controlled release (Paxil CR) manufactured by SmithKline Beecham (Cork) Limited - Cidra - Puerto Rico (reference formulation)
Study NCT01815177 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Arthroscopic transosseous fixation
Study NCT06568133 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: UIC201603 and co-administration of UIC201603 and UIC201604
Description: * UIC201603 2 Caps/day for 7 days~* Wash out 7 days~* UIC201603 2 Caps/day + UIC201604 1 Tabs/day for 7 days
Study NCT06568133 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: UIC201604 and co-administration of UIC201603 and UIC201604
Description: * UIC201604 1 Tabs/day for 7 days~* Wash out 7 days~* UIC201603 2 Caps/day + UIC201604 1 Tabs/day for 7 daysadministration of UIC201603 and UIC201604
Study NCT01815177 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Suture anchors
Study NCT02909972 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ALRN-6924
Description: Fixed dose of ALRN-6924 per cohort, administered IV, Days 1, 8, and 15 every 28 days.
Study NCT02909972 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ALRN-6924 in combination with cytarabine
Description: Cytarabine (100 or 200 mg/m2) will be administered as an IV infusion followed by ALRN-6924 on Days 1, 8, and 15 every 28 days.
Study NCT01329029 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Roflumilast
Description: 500 µg, once daily
Study NCT05100849 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Kinect-based cognitive training
Description: The Kinect-based group will be involved in the standard treatment protocol and will perform a 14-sessions cognitive training program that consists of instrumental activities of daily living simulations. The cognitive training content will be projected onto a wall and patients will interact with the content, i.e., the selection of the appropriate response, through movement (kinect).
Study NCT05100849 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Tablet-based cognitive training
Description: The Tablet-based group will be involved in the standard treatment protocol and will perform a 14-sessions cognitive training program that consists of instrumental activities of daily living simulations. Patients will interact with the cognitive training content through a tablet.
Study NCT02593890 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: THEYA Recovery Range
Description: Post-operative Lingerie made from viscose derived bamboo
Study NCT01692418 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ferric carboxymaltose
Description: 1000mg of ferric carboxymaltose will be administered as an i.v. infusion (100ml normal saline)
Study NCT01692418 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Normal saline
Description: Normal saline will be administered as an i.v. infusion (100ml normal saline)
Study NCT01692418 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Normal saline
Description: Normal saline will be administered as an i.v. infusion (100ml normal saline)
Study NCT02551302 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Solera™ Medtronic
Description: The control group will receive a monosegmental posterior lumbar spine fusion with an intervertebral cage (PLIF). Solera™ Medtronic
Study NCT02551302 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: CD HORIZON BalanC™ Medtronic
Description: The intervention group will receive a hybrid system with a PLIF and a flexible pedicle screw system above the fusion. Surgery will be performed with the following devices:~CD HORIZON BalanC™ Medtronic
Study NCT00068445 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: lamotrigine
Study NCT00068445 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Placebo
Study NCT01175161 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Copper T380A Intrauterine Device
Description: the Copper T380A IUD will be placed either 10 minutes to 48 hours postpartum, or 4-6 weeks postpartum.
Study NCT01329029 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: once daily
Study NCT03094572 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: visual motor tasks
Description: This exercise involves manipulating an object that corresponds to a racket, this racket has a virtual avatar that animated a virtual ball. The purpose is to make it bounce to a given height. This comes close to ping-pong game.
Study NCT04402177 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Methyl Prednisolonate
Description: Corticosteroid treatment
Study NCT04402177 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Methyl Prednisolonate
Description: Corticosteroid treatment
Study NCT00919269 — intervention group
Intervention type: OTHER
Intervention: Cytology Specimen Collection Procedure
Description: Correlative studies
Study NCT00919269 — intervention group
Intervention type: OTHER
Intervention: Laboratory Biomarker Analysis
Description: Correlative studies
Study NCT01751022 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Device: Attain Performa Pacing Lead (along with a standard CRT-D system)
Description: Implant and follow-up of study lead, separate analysis for each lead model
Study NCT02171468 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dabigatran high dose
Study NCT02171468 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dabigatran low dose
Study NCT01257867 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Lithia water
Description: Oral intake of approximately 2 litres (2L) daily for 4 weeks
Study NCT01257867 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Natural spring water with negligible lithium levels
Description: Oral intake of approximately 2 litres (2L) daily for 4 weeks
Study NCT01932164 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: maxillary alveolar graft by tissue engineering
Description: Extraction of deciduous teeth of cleft lip and palate patients to obtain mesenchymal stem cells;
Study NCT01932164 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bone tissue engineering using mesenchymal stem cells
Description: Secondary alveolar graft in patients with cleft lip and palate using using mesenchymal stem cell obtained from dental pulp of deciduous teeth (autogenous) associated with a biomaterial composed of collagen and hydroxyapatite.
Study NCT01034124 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: warfarin, vitamin K, midazolam
Description: warfarin tablet single dose (10 mg) vitamin K tablet single dose (10 mg) midazolam syrup single dose (5 mg)
Study NCT01034124 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: warfarin, vitamin K, midazolam
Description: warfarin tablet single dose (10 mg) vitamin K tablet single dose (10 mg) midazolam syrup single dose (5 mg)
Study NCT02632578 — intervention group
Intervention type: BIOLOGICAL
Intervention: 2015 Fluvax® vaccine, BioCSL (a licensed influenza vaccine)
Description: Subjects received licensed influenza vaccine (Fluvax®), 1ml intramuscular injection.
Study NCT01389973 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ustekinumab 90 mg
Description: Subcutaneous injections of ustekinumb 90 mg at Weeks 0 and 4 and every 8 weeks until the dose for the Long-Term Extension has been selected then every 8 weeks through Week 196 with the selected dose.
Study NCT01389973 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ustekinumab 45 mg
Description: Subcutaneous injections of ustekinumb 45 mg at Weeks 0 and 4 and every 8 weeks until the dose for the Long-Term Extension has been selected then every 8 weeks through Week 196 with the selected dose.
Study NCT01389973 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ustekinumab 180 mg
Description: Subcutaneous injections of ustekinumb 180 mg at Weeks 0 and 4 and every 8 weeks until the dose for the Long-Term Extension has been selected then every 8 weeks through Week 196 with the selected dose.